Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Theravance
Theravance
GSK,Theravance announce regulatory submission for Anoro Ellipta in Japan
Reuters
Mon, 04/22/13 - 11:13 am
Anoro Ellipta
Japan
COPD
GSK
Theravance
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 04/20/13 - 11:09 am
Vertex Pharmaceuticals
Theravance
Alkermes
Theravance Inc.: Today's Featured Health Care Laggard
The Street
Sat, 04/20/13 - 10:57 am
Theravance
Glaxo-Theravance Lung Drug Gains Backing of FDA Advisers
Bloomberg
Wed, 04/17/13 - 04:34 pm
GSK
Breo Ellipta
FDA
COPD
Theravance
Mixed Messages on COPD Drug, FDA Review Finds
Med Page Today
Wed, 04/17/13 - 11:13 am
FDA
COPD
Breo Ellipta
GSK
Theravance
Data may support efficacy of COPD combo therapy, FDA document says
The Fly on the Wall
Mon, 04/15/13 - 08:46 am
FDA
COPD
GSK
Theravance
Breo Ellipta
Theravance Seen Luring Glaxo Bid as Drugs Near FDA Nod: Real M&A
Bloomberg
Mon, 03/25/13 - 11:07 am
GSK
Theravance
M&A
Glaxo May Buy Theravance to Gain New Drugs, Piper Analysts Say
Bloomberg
Mon, 03/4/13 - 11:02 am
GSK
Theravance
M&A
Anoro
Breo Ellipta
4 Can't-Miss Health-Care Events This Week
Motley Fool
Mon, 03/4/13 - 10:46 am
Depomed
FDA
Serada
Breo Ellipta
COPD
GSK
Theravance
Aegerion
Sarepta
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Sun, 01/27/13 - 11:18 am
Theravance
GSK
Astellas
Vivus
Eli Lilly
Immunogen
Roche
M&A
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Fri, 01/25/13 - 10:40 am
Vivus
Theravance
Roche
MAP Pharmaceuticals
M&A
Immunogen
GSK
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Allergan
Theravance: Tempting To Investors As Well As Partners
Seeking Alpha
Wed, 01/9/13 - 07:58 am
GSK
Theravance
5 Drug Hopefuls That Are Going to Change Your Life: Part 5
Motley Fool
Fri, 12/21/12 - 10:54 am
LAMA/LABA
GSK
Theravance
COPD
Theravance’s Vibativ May Have Risk for Pneumonia Patients
Bloomberg
Tue, 11/27/12 - 10:31 am
Vibativ
pneumonia
Theravance
2 Important Decisions to Watch For This Week in the Biotech Sector
Motley Fool
Mon, 11/26/12 - 10:56 am
Theravance
Vibativ
cabozantinib
Exelis
medullary thyroid cancer
pneumonia
Promising Biotech Stocks With Upcoming FDA Catalysts
Seeking Alpha
Tue, 11/13/12 - 06:00 pm
FDA
Biogen Idec
Alexza
Dynavax
Theravance
For NovaBay, Simplicity Is The Father Of Invention
Seeking Alpha
Mon, 11/12/12 - 11:29 am
NovaBay
Allergan
new molecular entity
NME
Forest Labs
Merck
Pfizer
Theravance
Theravance: Still A Buy On Weakness
Seeking Alpha
Sun, 11/4/12 - 10:44 am
Theravance
Theravance's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Seeking Alpha
Wed, 10/31/12 - 11:43 am
Theravance
earnings
Merck & Co and Theravance sign $153 million cardio pact
Pharma Times, UK
Thu, 10/18/12 - 11:56 am
Merck
Theravance
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »